CML

Clinical trials for CML explained in plain language.

Never miss a new study

Get alerted when new CML trials appear

Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 2 Terminated 1

New drug may reduce dangerous side effects of stem cell transplants in older patients

Disease control Ongoing

This early-phase study tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) and reduce the need for long-term immune-suppressing medications after a stem cell transplant. The trial involves 32 older adults (age 60+) with certain…

Matched conditions: CML

Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated May 01, 2026 15:57 UTC

CML

Get alerted when new CML trials appear

New drug may reduce dangerous side effects of stem cell transplants in older patients